A common fruit found in everything from desserts to smoothies is now gaining attention in cancer research. Scientists are exploring whether compounds in dark sweet cherries could help slow the progression of one of the most aggressive forms of breast cancer.
In a recent study from Texas A&M University, researchers examined anthocyanins — natural plant compounds responsible for the deep red color of cherries. Using a mouse model of triple-negative breast cancer, they found that these compounds slowed tumor growth and reduced the spread of cancer to other organs.
Triple-negative breast cancer is particularly difficult to treat because it lacks common receptors that many therapies target. This makes it more aggressive and more likely to spread, highlighting the need for additional treatment approaches.
The study also found that when cherry compounds were combined with chemotherapy, tumor growth slowed earlier compared to chemotherapy alone. In addition, the mice maintained healthier body weight, suggesting the compounds may help support the body during treatment.
Researchers observed changes at the genetic level as well. The cherry-derived compounds appeared to reduce activity in genes linked to cancer spread and treatment resistance. They also influenced immune response, potentially helping the body better recognize and fight cancer cells.
While these findings are promising, they are still early. The research was conducted in mice, and scientists caution that results may not translate directly to humans. More studies are needed to understand how these compounds are absorbed in the body and how they might work alongside existing treatments.
For now, the takeaway is not that cherries can treat cancer, but that natural compounds found in foods may one day play a supportive role in comprehensive cancer care.
SOURCE:
MedicalXpress, March 15, 2026